Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials?

Biointerphases

Volumn 8, Issue 1, 2013, Pages 1-9

  Braune, Steffen ^a   Grunze, Michael ^b   Straub, Andreas ^c   Jung, Friedrich ^a  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOCOMPATIBILITY; IN-VITRO;

BIOMATERIAL;

ANIMAL; HUMAN; MATERIALS TESTING; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; MATERIALS TESTING;

EID: 84901277720     PISSN: 19348630     EISSN: 15594106     Source Type: Journal    
DOI: 10.1186/1559-4106-8-33     Document Type: Article

References (120)

1. Butler D (2011) UN targets top killers. Nature 477:260-261
2. Sanon S, Lenihan DJ, Mouhayar E (2011) Peripheral arterial ischemic events in cancer patients. Vasc Med 16:119-130
3. Lumsden AB, Davies MG, Peden EK (2009) Medical and endovascular management of critical limb ischemia. J Endovasc Ther 16:II31-II62
4. Aoki J, Lansky AJ, Mehran R, et al. (2009) Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the acute catheterization and urgent intervention triage strategy trial. Circulation 119:687-698
5. Jung F, Wischke C, Lendlein A (2011) Degradable, multifunctional cardiovascular implants: challenges and hurdles. MRS Bull 35:607-613
6. Erne P, Schier M, Resink TJ (2006) The road to bioabsorbable stents: reaching clinical reality? Cardiovasc Intervent Radiol 29:11-16
7. Joner M, Finn AV, Farb A, et al. (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193-202
8. Rossi ML, Zavalloni D, Gasparini GL, Presbitero P (2008) Very late multivessel thrombosis of bare metal stents with concomitant patent drug-eluting stents after withdrawal of aspirin. Int J Cardiol 131:e7-e9
9. Desai M, Seifalian AM, Hamilton G (2011) Role of prosthetic conduits in coronary artery bypass grafting. Eur J cardio-thoracic Surg 40:394-398
10. Park J-W, Leithäuser B, Gerk U, et al. (2009) Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. J Invasive Cardiol 21:446-450
11. Schoen FJ, Padera RF, Jr (2013) A-Substitute Heart Valves. In: Ratner BD, Hoffman A, Schoen FJ, Lemons JE (ed) Biomaterials Science-An Introduction to Materials in Medicine, 3rd edition. Elsevier Academic Press, Amsterdam, Heidelberg [a.o.], pp 761-771
12. Sims DB, Takayama H, Uriel N, et al. (2011) Ventricular assist deviceassociated thrombus. Circulation 124:e197-e198
13. Song Y, Feijen J, Grijpma DW, Poot AA (2011) Tissue engineering of smalldiameter vascular grafts: a literature review. Clin Hemorheol Microcirc 49:357-374
14. Sivaraman B, Latour R (2010) The relationship between platelet adhesion on surfaces and the structure versus the amount of adsorbed fibrinogen. Biomaterials 31:832-839
15. Sivaraman B, Latour R (2010) The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding. Biomaterials 31:1036-1044
16. Tengvall P (2011) Protein Interactions with Biomaterials, Compr. Biomater. Elsevier Ltd., Oxford, pp 63-73
17. Yu K, Lai BFL, Kizhakkedathu JN (2012) Carbohydrate structure dependent hemocompatibility of biomimetic functional polymer brushes on surfaces. Adv Healthc Mater 1:199-213
18. Cheng X, Canavan HE, Graham DJ, et al. (2006) Temperature dependent activity and structure of adsorbed proteins on plasma polymerized Nisopropyl acrylamide. Biointerphases 1:61
19. Jurk K, Kehrel BE (2005) Platelets: physiology and biochemistry. Semin Thromb Hemost 31:381-392
20. Gori T (2011) Viscosity, platelet activation, and hematocrit: progress in understanding their relationship with clinical and subclinical vascular disease. Clin Hemorheol Microcirc 49:37-42
21. Weyrich A, Cipollone F, Mezzetti A, Zimmerman G (2007) Platelets in atherothrombosis: new and evolving roles. Curr Pharm Des 13:1685-1691
22. Semple JW, Italiano JE, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264-274
23. Reinhart WH (2013) Platelets in vascular disease. Clin Hemorheol Microcirc 53:71-79
24. Nurden AT (2011) Platelets, inflammation and tissue regeneration. Thromb Haemost 105(Suppl):S13-S33
25. Sefton MV (2012) Nonthrombogenic materials and strategies: case study. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (ed) Biomaterials science: an introduction to materials in medicine, 3rd edition. Elsevier Academic Press [a.o.], Amsterdam, Heidelberg, pp 785-760
26. Ratner BD (2012) Biomaterials science: an introduction to materials in medicine, 3rd edition. Elsevier, Academic Pr, Amsterdam, Heidelberg [a.o.]
27. Ratner BD (1993) The blood compatibility catastrophe. J Biomed Mater Res 27:283-287
28. Ratner BD (2007) The catastrophe revisited: blood compatibility in the 21st century. Biomaterials 28:5144-5147
29. Seyfert U (2002) In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng 19:91-96
30. Thevenot P, Hu W, Tang L (2008) Surface chemistry influences implant biocompatibility. Curr Top Med Chem 8:270-280
31. Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86-100
32. Anderson JM (1988) Inflammatory response to implants. ASAIO Trans Am Soc Artif Intern Organs 34:101-107
33. Marmur A (2009) Solid-surface characterization by wetting. Annu Rev Mater Res 39:473-489
34. Hiebl B, Lützow K, Lange M, et al. (2010) Cytocompatibility testing of cell culture modules fabricated from specific candidate biomaterials using injection molding. J Biotechnol 148:76-82
35. Rickert D, Lendlein A, Schmidt AM, et al. (2003) In vitro cytotoxicity testing of AB-polymer networks based on oligo(epsilon-caprolactone) segments after different sterilization techniques. J Biomed Mater Res B Appl Biomater 67:722-731
36. Roch T, Pierce BF, Zaupa A, et al. (2011) Reducing the endotoxin burden of desaminotyrosine-and desaminotyrosyl tyrosine-functionalized gelatin. Macromol Symp 309-310:182-189
37. Lieder R, Petersen PH, Sigurjónsson OE (2013) Endotoxins-the invisible companion in biomaterials research. Tissue Eng Part B Rev 19:391-402
38. Gorbet MB, Sefton MV (2005) Endotoxin: the uninvited guest. Biomaterials 26:6811-6817
39. Franz S, Rammelt S, Scharnweber D, Simon JC (2011) Immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692-6709
40. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805-820
41. Rondina MT, Weyrich AS, Zimmerman GA (2013) Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 112:1506-1519
42. Roch T, Cui J, Kratz K, et al. (2012) Immuno-compatibility of soft hydrophobic poly (n-butyl acrylate) networks with elastic moduli for regeneration of functional tissues. Clin Hemorheol Microcirc 50:131-142
43. Jones CF, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61:438-456
44. Yliperttula M, Chung BG, Navaladi A, et al. (2008) High-throughput screening of cell responses to biomaterials. Eur J Pharm Sci 35:151-160
45. Krüger A, Braune S, Kratz K, et al. (2012) The influence of poly(n-butyl acrylate) networks on viability and function of smooth muscle cells and vascular fibroblasts. Clin Hemorheol Microcirc 52:283-294
46. Wischke C, Krüger A, Roch T, et al. (2013) Endothelial cell response to (co) polymer nanoparticles depending on the inflammatory environment and comonomer ratio. Eur J Pharm Biopharm 84:288-296
47. Li S, Henry JJD (2011) Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 13:451-475
48. Scharnagl N, Hiebl B, Trescher K, et al. (2012) Behaviour of fibroblasts on water born acrylonitrile-based copolymers containing different cationic and anionic moieties. Clin Hemorheol Microcirc 52:295-311
49. Cooperstein MA, Canavan HE (2013) Assessment of cytotoxicity of (Nisopropyl acrylamide) and poly(N-isopropyl acrylamide)-coated surfaces. Biointerphases 8:19
50. Trescher K, Roch T, Cui J, et al. (2013) Test system for evaluating the influence of polymer properties on primary human keratinocytes and fibroblasts in mono-and coculture. J Biotechnol 166:58-64
51. Van Oeveren W (2013) Obstacles in haemocompatibility testing. Scientifica (Cairo) 2013:1-14
52. Jung F, Braune S, Lendlein A (2013) Haemocompatibility testing of biomaterials using human platelets. Clin Hemorheol Microcirc 53:97-115
53. Oudemans-van Straaten HM, Kellum JA, Bellomo R (2011) Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care 15:202
54. Mousa SA (2010) Anticoagulants, antiplatelets, and thrombolytics. Methods Mol Biol 663. doi: 10.1007/978-1-60761-803-4
55. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (2004) Biomaterials Science-An Introduction to Materials in Medicine, 2nd edition. Elsevier Academic Press, Amsterdam, Heidelberg [a.o.], p 913
56. Hamad OA, Nilsson PH, Wouters D, et al. (2010) Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol 184:2686-92
57. Bexborn F, Engberg AE, Sandholm K, et al. (2009) Hirudin versus heparin for use in whole blood in vitro biocompatibility models. J Biomed Mater Res A 89:951-9
58. Alquwaizani M, Buckley L, Adams C, Fanikos J (2013) Anticoagulants: a review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep 1:83-97
59. Bussey H, Francis JL, Consensus Group TH (2004) Heparin overview and issues. Pharmacotherapy 24:103S-107S
60. Chang X, Gorbet M (2013) The effect of shear on in vitro platelet and leukocyte material-induced activation. J Biomater Appl 28:407-15
61. Sperling C, Maitz MF, Talkenberger S, et al. (2007) In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces. Biomaterials 28:3617-25
62. Wendel HP, Hauser N, Briquet F, Ziemer G (2002) Hemocompatibility of medical connectors with biopassive or bioactive surface coatings. J Biomater Appl 17:5-17
63. Waterhouse A, Yin Y, Wise SG, et al. (2010) The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents. Biomaterials 31:8332-40
64. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) The role of complement in biomaterial-induced inflammation. Mol Immunol 44:82-94
65. Mackie I, Cooper P, Lawrie A, et al. (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 35:1-13
66. Cattaneo M, Cerletti C, Harrison P, et al. (2013) Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 11:1183-1189
67. Cattaneo M, Hayward CPM, Moffat KA, et al. (2009) Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 7:1029
68. Koster A, Fischer K-G, Harder S, Mertzlufft F (2007) The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT. Biol Targets Ther 1:105-12
69. Kopp R, Bernsberg R, Kashefi A, et al. (2005) Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study. Int J Artif Organs 28:1272-7
70. Vienken J (2007) The need for a systems approach in biomaterials testing. Med Device Technol 18(12-14):16-7
71. Lippi G, Salvagno GL, Montagnana M, et al. (2012) Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 38:565-75
72. Smock KJ, Crist RA, Hansen SJ, et al. (2010) Discard tubes are not necessary when drawing samples for specialized coagulation testing. Blood Coagul Fibrinolysis an Int J Haemost Thromb 21:279-282
73. Raijmakers MTM, Menting CHF, Vader HL, Van Der Graaf F (2010) Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube. Am J Clin Pathol 133:331-335
74. Cole M, Price L, Parry A, et al. (2007) A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer. Pediatr Blood Cancer 48:687-695
75. Kalb ML, Potura L, Scharbert G, Kozek-Langenecker SA (2009) The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 20:7-11
76. Adcock DM, Hoefner DM, Kottke-Marchant K, et al. (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: approved guideline, CLSI document H21-A5 (ISBN 1-56238-657-3), 5th edition., Wayne, Pennsylvania, p 6
77. Adcock D, Kressin D, Marlar RA (1998) The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinolysis 9:463-470
78. Rao LV, Okorodudu AO, Petersen JR, Elghetany MT (2000) Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions. Clin Chim Acta 300:13-21
79. Breddin HK (2005) Can platelet aggregometry be standardized? Platelets 16:151-8
80. Cohen MG, Rossi JS, Garbarino J, et al. (2011) Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res 128:335-40
81. Endler G, Slavka G, Perkmann T, Haushofer A (2010) The importance of preanalytics for the coagulation laboratory. Haemostaseologie 30:63-70. quiz 71-2
82. Favaloro EJ, Adcock Funk DM, Lippi G (2012) Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Med 43:1-10
83. Böhm M, Täschner S, Kretzschmar E, et al. (2006) Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von willebrand factor: potential for misdiagnosis of haemophilia and von willebrand disease. Blood Coagul Fibrinolysis an Int J Haemost Thromb 17:39-45
84. Favaloro EJ, Soltani S, McDonald J (2004) Potential laboratory misdiagnosis of hemophilia and von willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol 122:686-92
85. Polderman KH (2012) Hypothermia and coagulation. Crit Care 16:A20
86. Straub A, Breuer M, Wendel HP, et al. (2007) Critical temperature ranges of hypothermia-induced platelet activation: possible implications for cooling patients in cardiac surgery. Thromb Haemost 97:608-616
87. Straub A, Krajewski S, Hohmann JD, et al. (2011) Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler Thromb Vasc Biol 31:1607-16
88. Breddin K (1968) In-vitro-Methoden zur Beurteilung der Plättchenfunktion. Blut 18:84-89
89. Frank RD, Dresbach H, Thelen H, Sieberth HG (2000) Glutardialdehyde induced fluorescence technique (GIFT): a new method for the imaging of platelet adhesion on biomaterials. J Biomed Mater Res 52:374-81
90. Braune S, Hönow A, Mrowietz C, et al. (2011) Hemocompatibility of soft hydrophobic poly(n-butyl acrylate) networks with elastic moduli adapted to the elasticity of human arteries. Clin Hemorheol Microcirc 49:375-90
91. Braune S, Alagöz G, Seifert B, et al. (2012) Automated image-based analysis of adherent thrombocytes on polymer surfaces. Clin Hemorheol Microcirc 52:349-55
92. Lange M, Braune S, Luetzow K, et al. (2012) Surface functionalization of poly (ether imide) membranes with linear, methylated oligoglycerols for reducing thrombogenicity. Macromol Rapid Commun 33:1487-92
93. Goldsmith HL, Bell DN, Braovac S, et al. (1995) Physical and chemical effects of red cells in the shear-induced aggregation of human platelets. Biophys J 69:1584-95
94. Goldsmith HL, Yu SS, Marlow J (1975) Fluid mechanical stress and the platelet. Thromb Diath Haemorrh 34:32-41
95. Schmid-Schonbein H, Rieger H, Fischer T (1980) Blood fluidity as a consequence of red cell fluidity: flow properties of blood and flow behavior of blood in vascular diseases. Angiology 31:301-319
96. Phillips DR, Teng W, Arfsten A, et al. (1997) Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 96:1488-1494
97. Kalman PG, McCullough DA, Ward CA (1990) Evacuation of microscopic air bubbles from dacron reduces complement activation and platelet aggregation. J Vasc Surg 11:591-8
98. Lemm W (1992) The Reference Materials of the European Communities: Results of Hemocompatibility Tests. Springer, Berlin, Heidelberg
99. The European Society for Biomaterials (1991) 9th european conference on biomaterials chester, UK 9-11th september, 1991 in conjunction with 2nd consensus conference on definitions in biomaterials 7-8th september, 1991 and IUPAC working party on blood compatibility. J Mater Sci Mater Med 2:62-62
100. Brash JL, Ten Hove P (1993) Protein adsorption studies on "standard" polymeric materials. J Biomater Sci Polym Ed 4:591-599
101. Bélanger MC, Marois Y (2001) Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review. J Biomed Mater Res 58:467-77
102. Hansen A, McMillan L, Morrison A, et al. (2011) Polymers for the rapid and effective activation and aggregation of platelets. Biomaterials 32:7034-41
103. Kottke-Marchant K, Bruce D (2012) Laboratory Hematology Practice. Wiley-Blackwell, Chichester, Hoboken, p 776
104. Hoffman R, Jr EJB, Silberstein LE, et al. (2012) Hematology: Basic Principles and Practice, 6th edition. Churchill Livingstone Elsevier, Philadelphia
105. Kitchens CS, Konkle BA, Kessler CM (2013) Consultative Hemostasis and Thrombosis, 3rd edition. Saunders Elsevier, Philadelphia
106. Myerson J, He L, Lanza G, et al. (2011) Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. J Thromb Haemost 9:1292-300
107. Koziara JM, Oh JJ, Akers WS, et al. (2005) Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 22:1821-8
108. Brash JL, Uniyal S (1979) Dependence of albumin-fibrinogen simple and competitive adsorption on surface properties of biomaterials. J Polym Sci Polym Symp 66:377-389
109. Brash JL (2000) Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Ed 11:1135-46
110. Cornelius RM, Shankar SP, Brash JL, Babensee JE (2011) Immunoblot analysis of proteins associated with self-assembled monolayer surfaces of defined chemistries. J Biomed Mater Res A 98:7-18
111. Rabe M, Verdes D, Seeger S (2011) Understanding protein adsorption phenomena at solid surfaces. Adv Colloid Interface Sci 162:87-106
112. Weber N, Wendel HP, Ziemer G (2002) Hemocompatibility of heparincoated surfaces and the role of selective plasma protein adsorption. Biomaterials 23:429-39
113. Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25:5681-703
114. Levy M, Hartman AR (1996) Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not. Int J Cardiol 53(Suppl):S81-7
115. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ (1990) Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29:623-32
116. Neubauer H, Setiadi P, Pinto A, et al. (2009) Upregulation of platelet CD40, CD40 ligand (CD40L) and P-selectin expression in cigarette smokers: a flow cytometry study. Blood Coagul Fibrinolysis 20:694-8
117. Gemmell CH, Sefton MV, Yeo EL (1993) Platelet-derived microparticle formation involves glycoprotein IIb-IIIa, inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 268:14586-9
118. Galper BZ, Mauri L (2013) Antiplatelet therapy after coronary stenting. Curr Treat Options Cardiovasc Med 15:1-10
119. Görlinger K, Bergmann L, Dirkmann D (2012) Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 26:179-98
120. Cho MJ, Liu J, Pestina TI, et al. (2003) The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation. Blood 101:2646-51